{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:26Z","timestamp":1783075886330,"version":"3.54.6"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/ftd.0b013e31828d221f","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T11:23:42Z","timestamp":1370431422000},"page":"539-545","source":"Crossref","is-referenced-by-count":7,"title":["Quetiapine and Norquetiapine Serum Concentrations and Clinical Effects in Depressed Patients Under Augmentation Therapy With Quetiapine"],"prefix":"10.1097","volume":"35","author":[{"given":"Elnaz","family":"Ostad Haji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirijam","family":"Fric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Laux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"R\u00f6schke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":". World Federation of Societies of Biological psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.","volume":"8","author":"Bauer","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":". Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.","volume":"68","author":"Papakostas","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.v68n0617","article-title":"Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.","volume":"68","author":"Crossley","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":". AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.08m04629","article-title":". Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.","volume":"70","author":"Bauer","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":". Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/FTD.0b013e31821160c4","article-title":". Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.","volume":"33","author":"Bakken","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","article-title":". The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.","volume":"12","author":"Brunello","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":". N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapines antidepressant activity.","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FTD.0b013e3182603f62","article-title":". Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors.","volume":"34","author":"Fisher","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":". The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pnpbp.2008.09.026","article-title":". Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.","volume":"33","author":"Figueroa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"R18-15-20210129","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.v68n1011","article-title":"Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.","volume":"68","author":"Castberg","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004714-200204000-00011","article-title":". Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.","volume":"22","author":"Potkin","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R20-15-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.yic.0000188213.46667.f1","article-title":". Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.","volume":"21","author":"Aichhorn","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R21-15-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/cap.2007.0084","article-title":". Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.","volume":"18","author":"Winter","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R22-15-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11597330-000000000-00000","article-title":". Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.","volume":"32","author":"Altamura","year":"2012","journal-title":"Clin Drug Investig"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jpsychires.2005.10.003","article-title":". Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.","volume":"41","author":"Muller","year":"2007","journal-title":"J Psychiatr Res"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31828d221f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:50Z","timestamp":1620952850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201308000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31828d221f","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}